P olyunsaturated fatty acids (PUFAs) are the essential fatty acids that are not synthesized de novo by mammals and must be consumed with ration. Excessive ω-6 PUFAs and high ω-6 to ω-3 ration in modern diet are important factors in pathogenesis of various diseases, including cancer [1] . ω-3 PUFAs have been described to have a protective effect against cancer progression, though its molecular mechanisms remain unexplained [2, 3] .
Consumed ω-3 PUFAs are integrated into cellular membranes and then metabolized in by cyclooxygenases, lipoxygenases and cytochrome P450 (CYP) [4] . ω-3 PUFAs conversion to oxygenated products by CYP-catalyzed metabolic pathway is one of the proposed mechanisms of their antitumor effects [5] , as these products may directly or indirectly affect growth and proliferation of cancer cells [6, 7] . Moreover, as components of membranes, ω-3 PUFAs help maintain functional state of components of monooxygenase system (MOS) in endoplasmic reticulum, which affects anticancer drug metabolism.
Thus, the aim of the study was to determine the variations in functioning of MOS components in microsomal fraction of Guerin's carcinoma under ω-3 PUFAs administration.
Materials and Methods
The experiments were performed on white female rats of 90-110 g body mass. The animal experiments were conducted in accordance with Recommendations in Methodology by Bioethics Expert Committee for Pre-Clinical and Other Studies Performed on Laboratory Animals (Kyiv, 2006). The animals were kept under standard conditions and fed granulated K-120-2 ration (Rezon-1, Ukraine). Guerin's carcinoma was used as a cancer model. 0.5 ml of 30% carcinoma cell suspension in normal saline was implanted subcutaneously into thigh of a hind leg [8] . The animals were assigned to the following groups: I -animals inoculated with Guerin's carcinoma (experimental control); II -animals that were administered ω-3 PUFAs prior-and post-Guedoi: http://dx.doi.org/10.15407/ubj88.04.048 rin's carcinoma injection; III -animals that were administered ω-3 PUFAs prior to Guerin's carcinoma injection; IV -animals that were administered ω-3 PUFAs post-Guerin's carcinoma injection.
ω-3 PUFAs were administered as Vitrum Cardio Omega-3 (Unipharm Inc., USA), derived from fish oil. The content of the pharmaceutical was analyzed by HRGC 5300 gas chromatographer (Italy) in glass column (3.5 m) with Chromosorb W/HP sorbent in 10% Silar 5CP liquid phase at 140-250 °C (2 °C per min heating). The fatty acids were identified by standard Sigma chemicals. The pharmaceutical was determined to contain 32% eicosapentaenoic acid and 24% docosahexaenoic acid.
The animals of the corresponding groups were administered ω-3 PUFAs for 4 weeks prior to the carcinoma implantation and then for the entire duration of tumor growth. Daily dose was 120 mg of ω-3 PUFAs per 1 kg of body mass.
The animals were decapitated under diethyl ether sedation at various stages of carcinoma develop ment: 7-day (latent carcinogenesis), 14-day (logarithmic carcinoma growth), and 21-day (stable size). Microsomal fraction was obtained by differen tial centrifugation [9] and used to assay cata lytic activity of NADH-cytochrome b 5 reductase (EC 1.6.2.2), cytochrome b 5 content and reduction rate [10] , and cytochrome P450 content and rate of inactivation (EC 1.14.14.1) [11] . The rate of cytochrome b 5 reduction was measured at λ = 424 nm and 475 nm at 30 sec intervals and expressed as ΔA per mg of protein. The rate of cytochrome P450 inactivation was measured at λ = 420 nm and 450 nm at 3 min intervals and expressed as ΔA per nmol of cytochrome P450.
The reactions of reductase and oxygenase electron-transport chains were initiated by NADH and NADPH, correspondingly. Production of O 2
•-was assayed in nitro blue tetrazolium (NBT) test [12] , in which NBT is reduced to hydrazine tetrazolium (with maximum absorbance at λ = 540 nm) in the presence of O 2
•-. Rate of O 2 •-production was expressed as nmol hydrazine tetrazolium per min per mg of protein (nmol·min -1 ·mg -1 of protein), assu ming that extinction of 0.325 corresponds to 325 nmol of superoxide radical [12] .
Protein content was measured by Lowry assay [13] . The data were processed by analysis of variance method using Student's t-test.
results and discussion
The hydroxylation of ω-3 PUFAs by isoforms of P450 depends largely on the reductive chain of MOS. Cytochrome-b 5 reductase, the first component of the chain, passes electrons to cytochrome b 5 , which in turn passes them to CYP on the fifth stage of the monooxygenase cycle. Changes in functioning of reductive chain of MOS may result in variation of produced metabolites and direction of CYP-catalyzed reactions [14] .
We determined the highest level of NADHcytochrome b 5 reductase activity during logarithmic growth phase of Guerin's carcinoma, with consecutive decrease (Fig. 1) . This corresponds to a decrease in cytochrome b 5 content in this period (Fig. 2) and increased rate of its oxidation and reduction (Fig. 3,  B) , which may compensate for the decrease in its quantity.
The intensive growth period of Guerin's carcinoma is thus associated with increased cytochromeb5 reductase activity and rate of cytochrome b 5 reduction, which increased electron transfer to CYP [15] .
The highest NADH-cytochrome b 5 reductase activity levels and the lowest cytochrome b 5 were detected in animals that were administered ω-3 PUFAs both prior to and post-Guerin's carcinoma implantation. The cytochrome b 5 reductase activity increased 1.5 times (Fig. 1) , and cytochrome b 5 content decreased 2.8 times during intensive tumor growth phase in the animals of this group in comparison to experimental control.
Higher NADH-cytochrome b5 reductase activity facilitates increased electron flow in MOS reductive chain. Yet under conditions of decreased cytochrome b 5 content the electrons may be transferred to molecular oxygen, raising its content 1.6 times that of control levels (Fig. 4) .
The parameters of activity of NADH-dependent reductive systems in animals administered ω-3 PUFAs after Guerin's carcinoma implantation did not differ from those of control group animals ( Fig. 1, 2, and 3) .
Administration of ω-3 PUFAs prior to carcinoma implantation leads to increased NADH-cytochrome b 5 reductase activity (Fig. 1) , decreased cytochrome b 5 content (Fig 2) and rate of cytochrome b 5 oxidation (Fig. 3) in comparison to control. Yet the changes are less pronounced than those of the group 
Fig. 2. cytochrome b 5 content in microsomal fraction of Guerin's carcinoma under administration of ω-3 PUFAs
Time after carcinoma implantation, days 
Fig. 3. the rate of cytochrome b5 reduction in microsomal fraction of Guerin's carcinoma under administration of ω-3 PUFAs. A -7 days after carcinoma implantation; B -14 days after carcinoma implantation; C -21 days after carcinoma implantation
Time, min As cytochrome b 5 is participating in reactions catalyzed by various CYP isoforms, its decreased content and reduction rate may adversely affect CYP functions.
We found decreased CYP content in microsomal fraction of Guerin's carcinoma in animals of the group that was administered ω-3 PUFAs both before and post-implantation of the carcinoma in comparison to control during initial and logarithmic phases of carcinogenesis (Fig. 5) . The decrease in CYP content may result from its inactivation and transformation in the inactive form, cytochrome P420 (Fig. 6) . CYP is processed into cytochrome P420 by modifications of thiol groups in the active center. Inactive cytochrome P420 is unstable and rapidly loses heme in the presence of oxygen [16] . Cytochrome P420 production thus serves as a stage of CYP degradation in Guerin's carcinoma cells under ω-3 PUFAs administration. Decreased CYP content may lead to disruptions in monooxygenase cycle. Oxygen may not be fully incorporated into substrate, but partially released from triple substrate-CYP-oxygen complex -(RH)
Fig. 4. the rate of superoxide generation by enzymes of reductive chain of MoS in microsomal fraction of Guerin's carcinoma under administration of ω-3 PUFAs
) as superoxide radical [16] . We have established that a decrease in CYP content is associated with increased rate of superoxide gene ration by oxygenative chain of MOS under ω-3 PUFAs administration prior to and post-Guerin's carcinoma implantation. O 2
•-generation rate is 1.7 times higher during initial stage and 1.9 times higher during logarithmic growth in comparison to control values (Fig. 7) . The generated superoxide initiates oxidative modifications of proteins, including MOS constituents, and lipid peroxidation in endoplasmic reticulum membranes [17] . Therefore, ω-3 PUFAs capacity to affect MOS action may be one of the mechanisms underlying their anticancer effect, due to a decrease in cytochrome b 5 and CYP content and increase in NADHcytochrome b 5 reductase activity, CYP inactivation rate, and superoxide generation in microsomal fraction of Guerin's carcinoma.
Fig. 6. The rate of CYP inactivation in microsomal fraction of Guerin's carcinoma under administration of ω-3 PUFAs. A -7 days after carcinoma implantation; B -14 days after carcinoma implantation; C -21 days after carcinoma implantation
We propose the following mechanisms for the observed ω-3 PUFAs influence of MOS:
1. ω-3 PUFAs may initiate lipid peroxidation in endoplasmic reticulum membranes followed by degradation of membrane-bound proteins, including MOS enzyme complexes; 2. ω-3 PUFAs increase generation rates of free radicals and reactive oxygen species by MOS enzymes;
3. ω-3 PUFAs are catabolized by CYP into oxidized derivatives that may affect proliferation and apoptosis of tumor cells. ) порівняно з контролем. Встановлено, що зниження вмісту цитохрому Р450 у мікросомній фракції карциноми Герена спостерігалося в логарифмічну фазу онкогенезу за введення ω-3 ПНЖК. Зниження вмісту цитохрому Р450 су-проводжувалося підвищенням швидкості його інактивації та переходу в неактивну форму -ци-тохром Р420. Показано, що зниження вмісту ци-тохрому Р450 відбувається на фоні підвищення генерації супероксидного радикала оксигеназ-ним ланцюгом МОС. К л ю ч о в і с л о в а: NADH-цитохром b 5 редуктаза, цитохром b 5 , цитохром Р450, супер-оксидний радикал, мікросомна фракція, карци-нома Герена, ω-3 поліненасичені жирні кислоти.
